8-K: Reliance Global Secures $10M Equity Line with White Lion Capital

Reliance Global Group, Inc. has entered into an agreement with White Lion Capital, LLC for a potential $10 million equity financing facility.

Summary

• Reliance Global Group, Inc. (RELI) entered into a Common Stock Purchase Agreement and a Registration Rights Agreement with White Lion Capital, LLC on August 26, 2025.
• The agreement grants the Company the right, but not the obligation, to sell up to an aggregate of $10,000,000 of its common stock to White Lion Capital.
• The commitment period for this facility commenced on August 26, 2025, and will end on the earlier of the full $10,000,000 commitment being purchased or December 31, 2027.
• The purchase price per share for each transaction will be the lowest traded price of the common stock during a three-hour valuation period following White Lion's acknowledgment of a purchase notice.
• The Company will pay a one-time $10,000 document preparation fee.
• As consideration for White Lion's commitment, the Company will issue $100,000 worth of common stock (Commitment Shares) in two $50,000 tranches, fully earned as of August 26, 2025.
• The issuance of shares is subject to an Exchange Cap of 19.99% of outstanding common stock (approximately 920,634 shares based on 4,471,484 shares outstanding as of the execution date), unless stockholder approval is obtained or the average price paid equals or exceeds $0.9196.
• A Beneficial Ownership Limitation prevents White Lion from acquiring shares that would result in beneficial ownership exceeding 4.99% (which can be increased to 9.99% with 61 days' notice).
• The Company is required to file a Form S-1 registration statement within ten business days after August 26, 2025, to allow White Lion to resell the shares.

Sentiment

Score: 6

Explanation: The agreement provides a flexible capital source, which is positive for financial stability and growth potential. However, the potential for dilution and the pricing mechanism based on the 'lowest traded price' during a valuation period introduce some downside risk for existing shareholders. It's a standard financing tool, neither exceptionally good nor bad, but necessary for capital access.

Positives

• Secures access to up to $10,000,000 in capital, providing financial flexibility for future operations or strategic initiatives.
• The Company has the option, but not the obligation, to draw on the facility, allowing it to manage dilution based on its capital needs and market conditions.
• The commitment shares ($100,000 worth) are fully earned by White Lion Capital as of the execution date, indicating immediate consideration for the commitment.
• The agreement includes a prohibition on White Lion Capital engaging in short sales during the commitment period, which could help mitigate downward pressure on the stock price from the investor.

Negatives

• Potential for significant shareholder dilution if the Company draws heavily on the facility, especially if the stock price is low at the time of issuance.
• The purchase price is based on the "lowest traded price" during a three-hour valuation period, which could result in sales at unfavorable prices for the Company.
• The $10,000 document preparation fee and the $100,000 in commitment shares represent a cost to the Company for securing the facility.
• The Exchange Cap and Beneficial Ownership Limitation may restrict the Company's ability to fully utilize the $10,000,000 facility without further shareholder approval or if the stock price falls below $0.9196.
• The Company is restricted from entering into similar equity line transactions for six months, limiting alternative financing options during that period.

Risks

• Dilution Risk: Issuance of new common stock to White Lion Capital will dilute the ownership interest of existing shareholders.
• Price Volatility Risk: The purchase price being the "lowest traded price" during a valuation period exposes the Company to selling shares at potentially depressed prices, especially in volatile markets.
• Market Overhang: The registration of a significant number of shares for resale by White Lion Capital could create an overhang on the market, potentially suppressing the stock price.
• Regulatory Compliance Risk: Failure to obtain necessary stockholder approval for exceeding the 19.99% Exchange Cap could limit the Company's access to the full $10,000,000 facility.
• Operational Risk: The Company's ability to utilize the facility is contingent on maintaining its NASDAQ listing and not having trading suspensions or halts.
• Information Disclosure Risk: Failure to promptly file a Form 8-K disclosing material non-public information provided to the investor could result in a $1,000 per day penalty.

Future Outlook

The Company has secured a flexible financing option to potentially raise up to $10 million through equity sales to White Lion Capital, which could support future operational needs or strategic growth initiatives through December 31, 2027. The Company plans to file a registration statement to facilitate the resale of these shares, indicating an intention to utilize this facility as needed.

Management Comments

• Reliance Global Group, Inc. entered into a common stock purchase agreement with White Lion Capital, LLC.
• The Company has the right, but not the obligation, to require White Lion to purchase, from time to time, up to an aggregate of $10,000,000 of newly issued shares of the Company's common stock.

Industry Context

This equity line facility provides Reliance Global Group, a company listed on The NASDAQ Capital Market, with a readily available source of capital. Such 'at-the-market' or equity line agreements are common financing tools for smaller-cap public companies, offering flexibility to raise funds as needed without the immediate dilution or fixed costs associated with traditional underwritten offerings. The structure allows the company to tap into capital markets based on its stock performance and specific funding requirements, aligning with broader trends of opportunistic financing in the small-cap sector.

Comparison to Industry Standards

• The $10 million commitment is a substantial amount for a company with approximately 4.47 million shares outstanding, indicating a significant potential capital injection relative to its current market capitalization.
• The "lowest traded price" during a valuation period for share purchases is a common, albeit often less favorable for the issuer, pricing mechanism in equity line facilities, similar to those seen in agreements with other institutional investors for small-cap companies.
• The 19.99% Exchange Cap and 4.99% (or 9.99%) Beneficial Ownership Limitation are standard provisions designed to comply with NASDAQ listing rules and prevent immediate change of control without shareholder approval, consistent with similar agreements across the industry.
• The $100,000 commitment shares and $10,000 document preparation fee are typical costs associated with securing such a facility, comparable to fees charged by institutional investors for providing similar capital access to other public companies.

Stakeholder Impact

• Shareholders: Potential for dilution from the issuance of new shares. The "lowest traded price" mechanism could lead to sales at less favorable prices. However, access to capital can support company growth and stability, potentially benefiting shareholders long-term.
• Company Operations: Provides a flexible source of capital to fund operations, working capital, or strategic initiatives without the immediate burden of debt.
• White Lion Capital: Gains the right to purchase shares at a discount to market prices (based on the lowest traded price during the valuation period) and receives commitment shares as consideration, with the ability to resell them.

Next Steps

• The Company will file a Current Report on Form 8-K, including the Transaction Documents as exhibits.
• The Company will file an initial registration statement on Form S-1 within ten business days after August 26, 2025, to register the resale of shares by White Lion Capital.
• The Company will use commercially reasonable best efforts to cause the registration statement to become effective as soon as practicable and keep it effective during the applicable registration period.
• The Company may, from time to time, deliver purchase notices to White Lion Capital to sell shares of common stock under the agreement.
• The Company will issue the $100,000 Commitment Shares in two tranches following their respective valuation dates and registration statement effectiveness.

Key Dates

Recommendation

While securing an equity line facility provides crucial financial flexibility and access to capital, the potential for significant dilution and the pricing mechanism (lowest traded price during a valuation period) introduce considerable risk for existing shareholders. The agreement is a standard financing tool for growth-oriented companies, but it doesn't present an immediate catalyst for strong upside. Investors should 'hold' to monitor how the company utilizes this capital, the rate of dilution, and its impact on future growth and profitability before making further investment decisions.

Keywords

Equity Line, Common Stock Purchase Agreement, Capital Raise, Dilution, SEC Filing, RELI, White Lion Capital, NASDAQ, Form S-1, Registration Rights, Shareholder Dilution, Investment, Financing, Public Company, Securities Exchange Act